Skip to main content

STEMPOINT CAPITAL LP

Position in SNDX — Syndax Pharmaceuticals Inc

CIK 1952142 NEW YORK, NY

Position in SNDX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$28,399,756
+$259,404 QoQ
Shares Held
1,215,743
-9.2% QoQ
Ownership
1.36%
of shares outstanding
% of Portfolio
5.54%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 88% Shared 0% None 12%

Common Shares in SNDX Over Time

Shares Held

Position Value (USD)

Derivatives in SNDX

reported options exposure · as of Mar 31, 2026
CallValue
$90,000
CallShares
150,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STEMPOINT CAPITAL LP holds $524,439,182 across 65 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in SNDX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $28,399,756 1,215,743
2026-03-31 $90,000 150,000
2025-12-31 $28,140,352 1,339,379
2025-09-30 $21,019,063 1,366,205
2025-09-30 $55,000 100,000
2025-06-30 $22,219,717 2,372,634
2025-03-31 $19,638,727 1,598,594
2024-12-31 $37,975,785 2,872,601
2024-12-31 $51,025 234,100
2024-09-30 $381,750 230,000
2024-09-30 $33,325,426 1,731,191
2024-06-30 $28,991,973 1,412,176
2024-03-31 $26,203,514 1,100,988
2023-12-31 $23,652,015 1,094,494